Vertex Pharmaceuticals Incorporated
Alan M Garber (Director) reports VRTX insider transactions
AI-generated summary
Director Alan M Garber received a grant of 29.272 Deferred Stock Units at an average price of $512.44 on October 15, 2026. The transaction was not made under a Rule 10b5-1 trading plan.
Key facts
- Insider
- Alan M Garber · Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | A · grantDeferred Stock UnitsFootnotes F1 | +29.272 | $512.44 | $15,000.14 | 94.73 | Direct |
Footnotes
- F1 Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death.
More VRTX filings
- 4
Filed Oct 22, 2026
- 3
Filed Oct 22, 2026
- 8-K
Filed Oct 20, 2026
- 4
Filed Oct 19, 2026
- 4
Filed Sep 10, 2026
- 3
Filed Sep 10, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.